Vikram Karnani insider trades

Open-market stock purchases and sales by Vikram Karnani, President and CEO at Collegium Pharmaceutical, Inc, from SEC Form 4 filings since Mar 23, 2017.

Recent trades

DateStockTradeValue
Feb 10, 2026COLL Collegium Pharmaceutical, IncBought (not open market)—
Feb 10, 2026COLL Collegium Pharmaceutical, IncBought (not open market)—
Feb 10, 2026COLL Collegium Pharmaceutical, IncSold (not open market)$528K
Dec 22, 2025DYN Dyne Therapeutics, IncBought (not open market)—
Nov 12, 2025COLL Collegium Pharmaceutical, IncSold (not open market)$425K

Companies traded

  • COLL Collegium Pharmaceutical, Inc: other filings, last Feb 10, 2026
  • DYN Dyne Therapeutics, Inc: other filings, last Dec 22, 2025
  • HZNP Horizon Therapeutics Public Ltd Co: 9 sales, last Feb 22, 2021

Get free alerts when Vikram Karnani files a new trade →